Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

Riepilogo

The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on November 14-15, 1996. The meeting will take place at the address provided below. All sessions of the meeting will be open to the public, except where specifically noted otherwise. Topics of discussion will include: (1) Discussion of Strategic Assessment and Direction Setting Issues Papers, (2) Status reports on (a) the Advance Notice for Proposed Rulemaking for Part 33, ``Specific Domestic Licensees of Broad Scope for Byproduct Material,'' (b) Modules for Regulatory Guide 10.8, ``Guide for the Preparation of Applications for Medical Use Programs,'' (c) Memorandum of Understanding with the U.S. Food and Drug Administration, and (d) Continuing Implementation of the Quality Management Rule; (3) discussion of regulatory authorization for intravascular brachytherapy, including the petition of IsoStent intravascular brachytherapy and the development of criteria and training and experience requirements; (4) discussion of security and control of byproduct materials in medical and university settings; (5) discussion of mobile high-dose-rate afterloader applicati